Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

CANCER:

Chronic Eosinophilic Leukemia

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related cancers:

‹

Leukemia (2148)

Acute Myelogenous Leukemia (1005)

Acute Lymphocytic Leukemia (419)

Chronic Lymphocytic Leukemia (326)

Chronic Myeloid Leukemia (266)

B Acute Lymphoblastic Leukemia (195)

Childhood B Acute Lymphoblastic Leukemia (39)

T Acute Lymphoblastic Leukemia (39)

Hairy Cell Leukemia (23)

Chronic Myelomonocytic Leukemia (20)

Prolymphocytic Leukemia (16)

Acute Promyelocytic Leukemia (12)

Juvenile Myelomonocytic Leukemia (5)

Chronic Neutrophilic Leukemia (3)

Leukemia (2148)

Acute Myelogenous Leukemia (1005)

Acute Lymphocytic Leukemia (419)

Chronic Lymphocytic Leukemia (326)

Chronic Myeloid Leukemia (266)

B Acute Lymphoblastic Leukemia (195)

Childhood B Acute Lymphoblastic Leukemia (39)

T Acute Lymphoblastic Leukemia (39)

Hairy Cell Leukemia (23)

Chronic Myelomonocytic Leukemia (20)

Prolymphocytic Leukemia (16)

Acute Promyelocytic Leukemia (12)

Juvenile Myelomonocytic Leukemia (5)

Chronic Neutrophilic Leukemia (3)

›

FIP1L1-PDGFRA fusion	Chronic Eosinophilic Leukemia	FIP1L1-PDGFRA fusion	Chronic Eosinophilic Leukemia	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1	imatinib Sensitive: A1 - Approval imatinib Sensitive : A1
KIT M541L	Chronic Eosinophilic Leukemia	KIT M541L	Chronic Eosinophilic Leukemia	imatinib Sensitive: C3 – Early Trials imatinib Sensitive : C3	imatinib Sensitive: C3 – Early Trials imatinib Sensitive : C3
PCM1-JAK2 fusion	Chronic Eosinophilic Leukemia	PCM1-JAK2 fusion	Chronic Eosinophilic Leukemia	ruxolitinib Sensitive: C3 – Early Trials ruxolitinib Sensitive : C3	ruxolitinib Sensitive: C3 – Early Trials ruxolitinib Sensitive : C3
FIP1L1-PDGFRA fusion	Chronic Eosinophilic Leukemia	FIP1L1-PDGFRA fusion	Chronic Eosinophilic Leukemia	Sensitive: C4 – Case Studies Sensitive : C4	Sensitive: C4 – Case Studies Sensitive : C4